Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook

About this update from Tenet Healthcare Corporation

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":245,"url":"https://media.zenfs.com/en/business-wire.com/6ee5608310198adde0edb6b7a147da2c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Ql8mPg2FT5H9soWbqut3lA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ5MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6ee5608310198adde0edb6b7a147da2c","width":480,"height":245}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Net income available to common shareholders in fourth quarter 2025 was $371 million, or $4.22 per diluted share","length":111,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":111,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted diluted earnings per share1 increased 36.6% to $4.70 in fourth quarter 2025 compared to $3.44 in fourth quarter 2024","length":125,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":125,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Consolidated Adjusted EBITDA1 in fourth quarter 2025 increased 12.9% to $1.183 billion compared to fourth quarter 2024; Fourth quarter 2025 Adjusted EBITDA margin was 21.4%","length":172,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":172,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Fourth quarter 2025 Ambulatory Care Adjusted EBITDA of $580 million increased 9.4% over fourth quarter 2024","length":107,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":107,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"FY 2026 Adjusted EBITDA Outlook is expected to be in the range of $4.485 billion to $4.785 billion","length":98,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":98,"olType":false},{"type":"text","content":"DALLAS, February 11, 2026--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2025.","length":161,"tagName":"p"},{"type":"text","content":""2025 extended Tenet's track record of strong revenue growth, disciplined operations, improved margins and robust free cash flow generation," said Saum Sutaria, M.D., Chairman and Ch...

More updates from Tenet Healthcare Corporation